Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics, sold MLTX on Jul 21, 2026
Data as of Oct 16
▼ SELL$1M50,000 shares at $20.02Kristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics
- Traded
- Jul 21, 2026
- Disclosed
- Jul 23, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MLTX since disclosure
−50.7%
after the sale
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund
Change in closing price from Jul 23, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$49Kdisclosed Jul 23 · filed 1 day after the trade